BIOR: Biora Therapeutics Inc Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 26.36
Enterprise Value ($M) 118.54
Book Value ($M) -97.44
Book Value / Share -10.53
Price / Book -0.27
NCAV ($M) -113.70
NCAV / Share -12.29
Price / NCAV -0.23

Profitability (mra)
Return on Invested Capital (ROIC) -3.48
Return on Assets (ROA) -1.08
Return on Equity (ROE) n/a

Liquidity (mrq)
Quick Ratio 1.69
Current Ratio 1.69

Balance Sheet (mrq) ($M)
Current Assets 46.36
Assets 62.61
Liabilities 160.06
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
03-13 13D/A Athyrium Opportunities 2020 LP 32.70 28.96
02-14 13G Armistice Capital, Llc 5.70

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2022-11-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2022-08-15 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2023-03-23 34,172 121,560 28.11
2023-03-22 28,573 61,859 46.19
2023-03-21 17,782 71,137 25.00
2023-03-20 21,101 79,269 26.62

(click for more detail)

Similar Companies
BHSE – Bull Horn Holdings Corp. BHSEU – Bull Horn Holdings Corp. Unit
BIIB – Biogen Inc BIVI – BioVie Inc
BLCM – Bellicum Pharmaceuticals Inc


Financial data and stock pages provided by
Fintel.io